RecruitingNCT02614911

Characterization of Phenotype and Genotype of Early Onset Enteropathies

Host-Microbiota Interactions Across the Gut Immune System: Characterization of Phenotype and Genotype of Early Onset Enteropathies

Sponsor

Imagine Institute

Enrollment

1,445 participants

Start Date

Jun 16, 2014

Study Type

OBSERVATIONAL

Conditions

Inflammatory Bowel Disease

Summary

This study has been set up in order to characterize phenotypes and genotypes of patients with early onset enteropathies. In that goal, Investigators will collect biological samples (mainly blood) of patients suffering from early onset enteropathies and their healthy relatives.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biological sampling for people with inflammatory bowel disease. The study is currently recruiting participants at 12 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiological sampling

Biological sampling including blood, feces, biopsies...

Locations(12)

Centre Hospitalier Pellegrin-Enfants

Bordeaux, France

Hôpital pédiatrique de Lyon

Bron, France

Hôpital Jeanne de Flandre, CHRU de Lille

Lille, France

Hôpital d'enfants de la Timone

Marseille, France

Hôpital Saint Antoine

Paris, France

Necker - Enfants Malades Hospital

Paris, France

Hôpital Robert Debré

Paris, France

Hôpital Trousseau

Paris, France

Hôpital Sud

Rennes, France

CHU Hautepierre

Strasbourg, France

Hôpital des Enfants

Toulouse, France

Hôpital Clocheville, CHU de Tours

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02614911

Related Trials

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT0381634552 locations

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT000011841 location

A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab

NCT075322131 location

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

NCT055793922 locations

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

NCT072422481 location